Research output per year
Research output per year
Personal profile
Research interests
Dr. Dubberke’s research focuses on the prevention, risk factors, and outcomes of Clostridium difficile-associated disease in the general hospitalized patient population as well as stem cell transplant recipients. He is also active in developing and evaluating infection prevention and treatment protocols in stem cell and solid organ transplant recipients.
Clinical interests
Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients, infections in cancer patients, fecal transplantation
Fingerprint
Dive into the research topics where Erik Dubberke is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
Okhuysen, P. C., Ramesh, M. S., Louie, T., Kiknadze, N., Torre-Cisneros, J., de Oliveira, C. M., Van Steenkiste, C., Stychneuskaya, A., Garey, K. W., Garcia-Diaz, J., Li, J., Duperchy, E., Chang, B. Y., Sukbuntherng, J., Montoya, J. G., Styles, L., Clow, F., James, D., Dubberke, E. R. & Wilcox, M., Jun 15 2024, In: Clinical Infectious Diseases. 78, 6, p. 1462-1472 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Clostridioides difficile infection across the lifespan: Estimation using life tables
Brown, D. S., Olsen, M. A., Keller, M. R., Stwalley, D., Tipping, A. D., Yu, H. & Dubberke, E. R., May 25 2024, In: Infection Control and Hospital Epidemiology. 45, 5, p. 681-683 3 p.Research output: Contribution to journal › Article › peer-review
-
Comparison of Clostridioides difficile nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs
Dumm, R. E., Burnham, C. A. D., Hink, T., Reske, K. A., Struttmann, E., Iqbal, Z. H., Cass, C., Kwon, J. H., Olsen, M. A. & Dubberke, E. R., Jan 2024, In: Journal of clinical microbiology. 62, 1Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection
Feuerstadt, P., Allegretti, J. R., Dubberke, E. R., Guo, A., Harvey, A., Yang, M., Garcia-Horton, V., Fillbrunn, M., Tillotson, G., Bancke, L. L., LaPlante, K., Garey, K. W. & Khanna, S., Jan 2024, In: Infectious Diseases and Therapy. 13, 1, p. 221-236 16 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting
Newcomer, E. P., Fishbein, S. R. S., Zhang, K., Hink, T., Reske, K. A., Cass, C., Iqbal, Z. H., Struttmann, E. L., Burnham, C. A. D., Dubberke, E. R. & Dantas, G., Mar 2024, In: mBio. 15, 3Research output: Contribution to journal › Article › peer-review
Open Access